Compare Globus Medical Inc. Class A Common Stock (GMED) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Realty Income Corp — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Realty Income Corp trades at $55.7 (market cap $52.20B). The key difference: Realty Income Corp is far larger — about 5.1× Globus Medical Inc. Class A Common Stock's market cap, and Realty Income Corp pays a 5.91% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Realty Income Corp for 128 Days on average.
| GMED | O | |
|---|---|---|
Market Cap | $10.25B | $52.20B |
Volume | 1,059,528 | 8,032,866 |
Sector | Health | Real Estate |
52-Week High | $96.82 | $67.56 |
52-Week Low | $58.33 | $53.35 |
Typical Hold Time | 0 Days | 128 Days |
Enterprise Value | $9.76B | $82.83B |
Dividend Yield | — | 5.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Realty Income (O) trades at $54.99, up 0.53% on the day, but remains in a bearish technical trend amid recent earnings misses. The stock's valuation appears elevated with a P/E of 40.14 and P/S of 8.53, though profitability is strong with a 92.56% gross margin. Recent news highlights the stock's decline as Treasury yields rise, pressuring REIT valuations, while the company maintains a robust dividend history with consistent monthly payouts.
Outlook: Moderate upside to the $64.16 consensus price target exists, supported by solid fundamentals and high analyst buy ratings, but risks include interest rate sensitivity, debt growth, and competitive pressures. The stock offers income appeal but faces near-term headwinds from macroeconomic conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
